Danny Grannick is the CEO and co-founder of Bristle. He received his BA in Biochemistry from the University of San Diego. After receiving his degree, Danny moved into a variety of commercial roles at leading genomics companies including Illumina and Oxford Nanopore. His passion is in bridging the gap between innovation on the bench and implementation at the bedside.